MARTY BALLARD: Open Payments
NPI 1023622081 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 92 payments from 15 companies in 2025. Trend: 2023 $219 · 2024 $1,150 · 2025 $1,780
Food & beverage: $1,775Education: $4
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $293 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $283 |
| Corcept Therapeutics | 9 | $206 |
| ABBVIE INC. | 17 | $195 |
| Lilly USA, LLC | 9 | $157 |
| Inspire Medical Systems, Inc. | 2 | $147 |
| Novo Nordisk Inc | 6 | $110 |
| PFIZER INC. | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| Viatris Specialty LLC | 3 | $61 |
Products named: CAPLYTA, Korlym, INSPIRE, BREZTRI, MOUNJARO, NURTEC ODT, JARDIANCE, Ozempic.
Industry payments across MS — which companies pay providers there.
